Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”

dc.contributor.authorSae-sim N.
dc.contributor.authorSamarnthai N.
dc.contributor.authorNumprasit W.
dc.contributor.correspondenceSae-sim N.
dc.contributor.otherMahidol University
dc.date.accessioned2026-06-05T18:16:19Z
dc.date.available2026-06-05T18:16:19Z
dc.date.issued2026-05-01
dc.identifier.citationCurrent Oncology Vol.33 No.5 (2026)
dc.identifier.doi10.3390/curroncol33050248
dc.identifier.eissn17187729
dc.identifier.scopus2-s2.0-105040136829
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/117090
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleReply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105040136829&origin=inward
oaire.citation.issue5
oaire.citation.titleCurrent Oncology
oaire.citation.volume33
oairecerif.author.affiliationSiriraj Hospital

Files

Collections